Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ELI LILLY AND COMPANY

(LLY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Eli Lilly and : Donating COVID-19 Baricitinib Tablets to India

05/04/2021 | 10:14am EDT


ę MT Newswires 2021
All news about ELI LILLY AND COMPANY
06/11ELI LILLY ANDá : Significant Insider Selling in Shares of Eli Lilly (LLY) Contin..
MT
06/11INSIDER TRENDS : Insider Sales Continue 90-Day Trend at Eli Lilly
MT
06/11ELI LILLY ANDá : Thinking about trading options or stock in Crispr Therapeutics,..
PR
06/11MARKET CHATTER : Eli Lilly Says Internal Inquiry Shows No Wrongdoings in Stateme..
MT
06/10INSIDER TRENDS : Insider Prolongs Selling Trend at Eli Lilly
MT
06/10MARKET CHATTER : Eli Lilly Reportedly Says Internal Inquiry Shows Company Did No..
MT
06/10STREET COLOR : Eli Lilly Memo States Company Did Not Make False Statements to FD..
MT
06/10ALX ONCOLOGYá : to Collaborate With Lilly on Combination Therapy for Gastric Can..
MT
06/10ALX Oncology, Eli Lilly to Evaluate Gastric Cancer Treatment
DJ
06/09ELI LILLY ANDá : Insider Selling in Eli Lilly (LLY) Shares Continues
MT
More news
Financials (USD)
Sales 2021 27 273 M - -
Net income 2021 6 537 M - -
Net Debt 2021 11 042 M - -
P/E ratio 2021 30,8x
Yield 2021 1,49%
Capitalization 204 B 204 B -
EV / Sales 2021 7,87x
EV / Sales 2022 7,66x
Nbr of Employees 35 000
Free-Float 99,8%
Chart ELI LILLY AND COMPANY
Duration : Period :
Eli Lilly and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ELI LILLY AND COMPANY
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 217,94 $
Last Close Price 224,09 $
Spread / Highest target 13,3%
Spread / Average Target -2,74%
Spread / Lowest Target -21,9%
EPS Revisions
Managers and Directors
NameTitle
David A. Ricks Chairman, President & Chief Executive Officer
Anat Ashkenazi Chief Financial Officer & Senior Vice President
Timothy J. Garnett Chief Medical Officer & VP-Global Medical
Daniel M. Skovronsky Chief Scientific Officer & Senior Vice President
Diogo Rau Senior VP, Chief Information & Digital Officer
Sector and Competitors
1st jan.Capitalization (M$)
ELI LILLY AND COMPANY32.72%203 704
JOHNSON & JOHNSON4.82%434 405
ROCHE HOLDING AG10.68%328 612
PFIZER, INC.9.07%224 747
NOVARTIS AG-0.39%208 035
ABBVIE INC.7.72%203 857